Montecito Bank & Trust’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Montecito Bank & Trust’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-5,135	Closed	-$186K	–	345
2016 Q4	$186K	Buy	+5,135	New	+$205K	0.06%	185
2016 Q3	–	Sell	-5,060	Closed	-$254K	–	186
2016 Q2	$254K	Sell	5,060 -817	-14%	-$43.5K	0.11%	150
2016 Q1	$314K	Sell	5,877 -220	-4%	-$12.9K	0.14%	122
2015 Q4	$400K	Sell	6,097 -281	-4%	-$17.4K	0.19%	106
2015 Q3	$360K	Buy	6,378 +628	+11%	+$40.7K	0.2%	102
2015 Q2	$358K	Hold	5,750	–	–	0.18%	111
2015 Q1	$358K	Buy	5,750 +236	+4%	+$13.7K	0.18%	111
2014 Q4	$317K	Buy	+5,514	New	+$307K	0.17%	120

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Montecito Bank & Trust's TEVA Position: Q1 2017 in Review

Montecito Bank & Trust sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2017, closing a stake of 5,135 shares — an estimated $186K sold.

Montecito Bank & Trust first reported a position in TEVA in Q4 2014 and held it in 8 quarters. The position peaked at $400K in Q4 2015. 688 funds tracked by Wall St. Rank hold TEVA as of Q1 2017.

Montecito Bank & Trust reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2017 after selling out during the quarter.
Montecito Bank & Trust sold 5,135 Teva Pharmaceutical Industries Limited shares in Q1 2017, an estimated $186K.
Montecito Bank & Trust first reported a position in Teva Pharmaceutical Industries Limited in Q4 2014 and held it in 8 quarters.
Montecito Bank & Trust's Teva Pharmaceutical Industries Limited position peaked at $400K in Q4 2015.
688 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2017.

Based on Montecito Bank & Trust's 13F filing for Q1 2017, filed 5 May 2017.